Are patients getting the gist in risk communication? patient understanding of prognosis in breast cancer treatment

Journal of Cancer Education

Volumn 24, Issue 3, 2009, Pages 194-199

  Hutton, David W ^a,c   Belkora, Jeffrey K ^b   Shachter, Ross D ^a   Moore, Dan H ^b  

^a Stanford University   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER THERAPY; CLINICAL ARTICLE; FEMALE; HORMONAL THERAPY; HUMAN; INTERPERSONAL COMMUNICATION; PATIENT EDUCATION; PILOT STUDY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; THEORETICAL MODEL;

ADULT; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMMUNICATION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; PILOT PROJECTS; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 66149185166     PISSN: 08858195     EISSN: None     Source Type: Journal    
DOI: 10.1080/08858190902876452     Document Type: Article

References (16)

1. Ravdin PM, Siminoff LA, Davis GJ, et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol. 2001;19:980-991.
2. Olivotto IA, Bajdik CD, Ravdin PM, et al. Population-based validation of the prognostic model adjuvant! For early breast cancer. J Clin Oncol. 2005;23:2716-2725.
3. Love N. Management of breast cancer in the adjuvant and metastatic settings. Patterns Care Med Oncol. 2005;2:10-24.
4. Peele PB, Siminoff LA, Xu Y, et al. Decreased use of adjuvant breast cancer therapy in a randomized controlled trial of a decision aid with individualized risk information. Med Decis Making. 2005;25:301-307.
5. Brainerd CJ, Reyna VF. Gist is the grist: fuzzy-trace theory and the new intuitionism. Dev Rev. 1990;10:3-47.
6. Reyna VF, Brainerd CJ. Fuzzy-trace theory: an interim synthesis. Learn Indiv Diff. 1995;7:1-75.
7. Hegel MT, Moore CP, Collins ED, et al. Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer. 2006;107:2924-2931.
8. Ahles TA, Saykin AJ, McDonald BC, et al. Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat. 2007;110:143-152.
9. Rugo HS, Ahles T. The impact of adjuvant therapy for breast cancer on cognitive function: Current evidence and directions for research. Semin Oncol. 2003;30:749-762.
10. Lloyd A, Hayes P, Bell PR, et al. The role of risk and benefit perception in informed consent for surgery. Med Decis Making. 2001; 21:141-149.
11. Belkora JK, Rugo HS, Moore DH, et al. Oncologist use of the adjuvant! Model for risk communication: a pilot study examining patient knowledge of 10-year prognosis. BMC Cancer; 2009;9:27. [Epub ahead of print]
12. McNemar Q. Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika. 1947;12:153-157.
13. Reyna VF, Adam MB. Fuzzy-trace theory, risk communication, and product labeling in sexually transmitted diseases. Risk Anal. 2003; 23:325-342.
14. Gattellari M, Butow PN, Tattersall MH, et al. Misunderstanding in cancer patients: why shoot the messenger? Ann Oncol. 1999; 10:39-46.
15. Ravdin PM, Siminoff IA, Harvey JA. Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. J Clin Oncol. 1998;16:515-521.
16. Epstein RM, Alper BS, Quill TE. Communicating evidence for participatory decision making. JAMA. 2004;291:2359-2366.